Opdivo®+Yervoy®

Opdivo® (nivolumab) is a prescription medicine used in combination with Yervoy® (ipilimumab) and 2 cycles of chemotherapy that contains platinum and another chemotherapy medicine, as a first treatment for adults with a type of advanced stage lung cancer (called non-small cell lung cancer) when your lung cancer has spread or grown, or comes back, and your tumor does not have an abnormal EGFR or ALK gene.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Opdivo®+Yervoy Referral Form

 

WHAT IT TREATS:
MANUFACTURER:

Bristol Myers Squibb

CLASS:
immunotherapies
PRESCRIBED BY:

Pulmonologist
Oncologists

 

 

HOW ADMINISTERED:
IV Infusion
FREQUENCY:

Every three weeks

 

 

Length of infusion:
60 - 90 mins